HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating
Wells Fargo Adjusts Price Target on Apple to $275 From $225, Maintains Overweight Rating
Meta Platforms Analyst Ratings
Oppenheimer Adjusts Price Target on Meta Platforms to $525 From $500, Maintains Outperform Rating
New Street Adjusts Price Target on Alphabet to $210 From $200, Maintains Buy Rating
Morgan Stanley Reiterates Overweight on Tesla, Maintains $310 Price Target
Deutsche Bank Adjusts Price Target on Meta Platforms to $525 From $500
Microsoft Analyst Ratings
TD Cowen Adjusts Price Target on Microsoft to $495 From $470, Maintains Buy Rating
Mizuho Adjusts Price Target on Alphabet to $205 From $190, Maintains Outperform Rating
Goldman Sachs Adjusts Price Target on Apple to $265 From $238, Maintains Buy Rating
Needham Remains a Buy on Amazon (AMZN)
CFRA Remains a Buy on Apple (AAPL)
Tesla Analyst Ratings
Apple Analyst Ratings
CFRA Maintains Buy on Apple, Raises Price Target to $260
UBS Reaffirms Their Hold Rating on Apple (AAPL)
Cantor Fitzgerald Reiterates Overweight on Tesla, Maintains $230 Price Target
Alphabet Analyst Ratings
TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850